← Eichor
Condition: Plaque Psoriasis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Plaque Psoriasis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psorias
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT05744466Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
EARLY_Phase 1 · 1 location(s) · Lahore General Hospital · NCT07261306A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · 18 location(s) · Huabo Biopharm Co., Ltd. · NCT06592274Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06792487A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Phase 2 · 20 location(s) · InventisBio Co., Ltd · NCT07489885A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
Phase 4 · 9 location(s) · Bausch Health Americas, Inc. · NCT03987763A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With
Phase 3 · 63 location(s) · Bristol-Myers Squibb · NCT04772079A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dos
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07532486A Phase 3 Clinical Study of QL2106 Injection
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07511647A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
Phase N/A · 3 location(s) · Novartis Pharmaceuticals · NCT07683065Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis
EARLY_Phase 1 · 1 location(s) · Wright State University · NCT04036188A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
Phase 1 · 1 location(s) · Usynova Pharmaceuticals Ltd. · NCT07038720Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
Phase 1 · 3 location(s) · SFA Therapeutics · NCT05642182A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults
Phase 2 · 1 location(s) · Ahmed Ibrahim · NCT07233291ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar
Phase N/A · 1 location(s) · Celltrion HealthCare France · NCT06997055Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis
Phase 2 · 36 location(s) · Oruka Therapeutics, Inc. · NCT07290569A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · 40 location(s) · Eli Lilly and Company · NCT06857942Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PRE
Phase 4 · 17 location(s) · Instituto de Investigación Marqués de Valdecilla · NCT07611747To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Present
EARLY_Phase 1 · 1 location(s) · Syeda Sana Zaman · NCT07337434A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx®
Phase 1 · 14 location(s) · UCB Biopharma SRL · NCT06888193A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With S
Phase 4 · 1 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07663331A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
Phase N/A · 2 location(s) · Bristol-Myers Squibb · NCT06382987ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
Phase 4 · 1 location(s) · Psoriasis Treatment Center of Central New Jersey · NCT04347473Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
Phase N/A · 1 location(s) · First Hospital of China Medical University · NCT06696417A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants Wit
Phase 3 · 129 location(s) · Bristol-Myers Squibb · NCT06979453A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)
Phase N/A · 1 location(s) · Almirall, S.A. · NCT06029257A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in
Phase N/A · 1 location(s) · Almirall, S.A. · NCT06030076Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
Phase N/A · 1 location(s) · NHS Greater Glasgow and Clyde · NCT06786936Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?
Phase 2 · 7 location(s) · Centre Hospitalier Universitaire de Nice · NCT06742333A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis
NA · 1 location(s) · Usynova Pharmaceuticals Ltd. · NCT07234591
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.